HGH (Somatropine) — 15mg / 45 IE

HGH (Somatropin) is recombinant human growth hormone produced via recombinant DNA technology, with a 191-amino-acid sequence identical to endogenous human growth hormone. Each vial contains 15mg (45 IU) of lyophilized somatropin, ≥99% purity, pharmaceutical grade with COA. Unlike secretagogues — which stimulate the body's own GH production — somatropin is the growth hormone itself. It binds the GH receptor and exerts both direct effects (lipolysis, fat breakdown) and IGF-1-mediated effects (protein synthesis, muscle, tissue and skeletal growth). Somatropin is researched and clinically used for growth hormone deficiency, tissue repair, body composition and anti-aging. Protocols range from 1–3 IU per day (anti-aging and fat loss) to 4–6 IU per day (muscle building), administered subcutaneously. Requires reconstitution with bacteriostatic water. Store refrigerated (2–8°C). For laboratory and research use only.

Post Cycle Therapy (PCT) is not required after somatropin use. It does not directly affect testosterone production, though prolonged suppression of the body's own GH axis is possible at high doses.